Interestingly, DDX5, but not DDX17, affect key cellular pathways, including upregulation of AR in PCa and induction of epithelial-mesenchymal transition (EMT), a feature that is associated with tumor invasion capabilities [22, 35, 36]. The gene discussed is DDX5; the disease is posterior cortical atrophy.